05.04.2017 14:25:00
|
Marijuana Market Offers Variety of Investment Options and Consistent, Long-Lasting Growth Potential
NEW YORK, April 5, 2017 /PRNewswire/ --
NetworkNewsWire Editorial Coverage
With the North American cannabis market boasting an estimated worth of $7.2 billion in 2016, and new reports projecting CAGR between 17 percent and 25 percent within the next few years, it's certainly an exciting time to invest in the marijuana market. Investment opportunities are abundant and diverse with companies like SinglePoint, Inc. (OTC: SING) (SING Profile), Innovative Industrial Properties Inc. (NYSE: IIPR), Insys Therapeutics Inc. (NASDAQ: INSY), MassRoots Inc. (OTC: MSRT) and Axim Biotechnologies Inc. (OTC: AXIM).
The marijuana market is on fire for more reasons than one. First, there's the huge potential for financial growth. A recent report from New Frontier Data estimates that medical marijuana sales in the United States will increase to $13.3 billion in 2020, and adult recreational marijuana sales are projected to grow to $11.2 billion by the same year. Then, there is the potential for massive job-creation. The same New Frontier Data report estimates that over a
quarter of a million jobs will be created within the legal marijuana market by 2020[1].
A report from leading cannabis market research publisher, Arcview Market Research, has compared the marijuana market's explosive growth to the cable television boom of the 1990s and the broadband Internet takeoff of the 2000s. Statements issued by Arcview, predict the legalization of marijuana in a significant number of countries within the next decade-and-a-half, crediting the cannabis industry with the most consistent and long-term growth potential the world has ever seen[2].
The possibilities and opportunities are virtually endless within the legalized marijuana market. The business plan of one innovative company, SinglePoint (SING), doesn't involve actual contact with marijuana plants but rather focuses on providing services to the marijuana industry.
For instance, through its SingleSeed subsidiary, SinglePoint is positioned to offer payment solutions to the cannabis industry. Mobile marketing and payment solutions offered through SingleSeed include cashless ATM, Pay-by-Text™ and text message marketing. While medical marijuana often takes center stage in discussions pertaining to legalization, the power cord for any marijuana business is the ability to conduct financial transactions, in what - for the time being - is largely an "unbankable" industry. SinglePoint CEO, Greg Lambrecht in a recent Forbes article[3] highlighted the possibility of change under the Trump Administration.
"The current administration has made it very clear that they would like to empower the states, and Trump has even stated his belief in how medical marijuana can help people. We believe the administration will stick to their word on empowering the states. In Phoenix, we have many medical shops, none of which have relayed to us that they are being impacted yet by the administration. The biggest impact the current administration can have in favor of cannabis in the near term would be to give guidelines on how this business can be banked," stated Lambrecht.
Meanwhile, the SingleSeed.com website is a prime resource for marijuana dispensaries that are seeking merchant payment processing solutions and other business tools.
SinglePoint also recently acquired an interest in the California-based Convectium, a profitable provider of equipment, branding and packaging solutions for the cannabis industry. Convectium is the developer of the first-ever cartridge and vape pen oil filling machines created for wholesale distribution to marijuana dispensaries. The company's 710Shark and 710Seal machines are able to fill and package more than 100 cartridges or disposable vape pens in 30 seconds. These machines are sold to dispensaries through the EquipCanna.com brand. Convectium further operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in more than 52 countries.
This diversified, "hands-off" approach shields SinglePoint against any legal repercussions, should the federal government surprise with a clampdown on the marijuana industry.
"There's no reason why they would ever come after us. We provide all of the products these dispensaries need, to do business, but we don't touch the plant," Lambrecht told The Hill[4].
Another company geared up to capitalize on the legalized marijuana boom, also without touching the plant, is Innovative Industrial Properties Inc. (NYSE: IIPR). IIPR specializes in acquiring freestanding properties that are used for cultivating licensed medical marijuana and that are operated by state-licensed growers. Once acquired, these properties are leased back to the growers under long-term, net lease agreements. This acquisition strategy acts as a source of capital to these growers. When they sell their real estate locations to IIPR and then lease them back from the company, the growers have an opportunity to redeploy those proceeds into their core operations, thereby yielding a higher return than they would get from owning their real estate.
Also tapping into the cannabis market in an outside-the-box way is MassRoots Inc. (OTCQB: MSRT). MassRoots is a leading technology platform for the marijuana industry. The registered users - currently numbered at over 1 million - can rate cannabis products and strains according to their effectiveness. MassRoots then offers this information in simple-to-use formats to help consumers make informed purchasing decisions at their local marijuana dispensaries.
Cashing in on the medical applications of legalized marijuana is Insys Therapeutics Inc. (NASDAQ: INSY). This specialty pharmaceutical company is focused on addressing the clinical inadequacies of existing commercial products through its proprietary sublingual spray technology and its pharmaceutical cannabinoids development capability. Insys is currently marketing two products. The first is Subsys, which is a sublingual Fentanyl spray for breakthrough cancer pain; the second is a generic version of Dronabinol (THC) capsules.
Axim Biotechnologies Inc. (OTCQB: AXIM) is also taking a medical approach in the cannabis market, focusing on researching, developing and producing cannabinoid-based pharmaceuticals and supplements. Axim owns the patent for using chewing gum as a cannabinoid delivery method and has developed two chewing gum-based products. The company's cannabidiol (CBD)-only Canchew gum is being marketed as a dietary supplement. AXIM will also soon commence phase 3 clinical trials for the combination CBD/THC gum MedChew RX, which is used to treat pain and spasticity associated with multiple sclerosis.
As the marijuana industry blazes forward, it's clear that opportunities and applications in the cannabis market are plentiful. Innovative companies like SinglePoint.com and others mentioned offer prime investment opportunities for those looking to capitalize in the rapidly growing marijuana field
Editorial Sources:
For more information on Singlepoint visit: Singlepoint, Inc. (SING) or http://www.SinglePoint.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today's market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
http://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
DISCLAIMER: NetworkNewsWire (NNW) is a source of content listed above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer or comparison to the profiled issuer. FN Media Group, LLC (FNM), is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with NNW or any company mentioned herein. The commentary, views and opinions expressed in this release by NNW are solely those of NNW and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this content agree that they cannot and will not seek to hold liable NNW and FNM for any investment decisions by their readers or subscribers. FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker-dealer/analyst/adviser, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM was not compensated by any public company mentioned herein to disseminate this press release. NNW's compensation disclosure is incorporated herein and appears in full at http://NNW.fm/Disclaimer
NNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW & FNM undertakes no obligation to update such statements.
Media Contact
E-mail: FN Media Group, LLC - editor@financialnewsmedia.com
+1-(954)345-0611
SOURCE NetworkNewsWire
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Innovative Industrial Propertiesmehr Nachrichten
05.11.24 |
Ausblick: Innovative Industrial Properties zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) | |
22.10.24 |
Erste Schätzungen: Innovative Industrial Properties veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net) | |
04.08.24 |
Ausblick: Innovative Industrial Properties legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) |
Analysen zu Innovative Industrial Propertiesmehr Analysen
Aktien in diesem Artikel
AXIM Biotechnologies Inc | 0,00 | -6,25% | |
Innovative Industrial Properties | 95,82 | 0,46% |